Stock Track | Haemonetics Soars 5.27% as Needham Raises Price Target to $78

Stock Track

Nov 07, 2025

Haemonetics (HAE) stock is soaring 5.27% in pre-market trading on Friday, following a positive analyst action. The surge comes after Needham raised its price target for the company from $68 to $78, signaling increased confidence in Haemonetics' future performance.

The raised price target represents a significant vote of confidence in Haemonetics' business prospects. This optimistic outlook from Needham appears to be driving investor enthusiasm, resulting in the stock's notable pre-market rally.

Adding to the positive sentiment, Barrington Research has maintained its Outperform rating on Haemonetics, further reinforcing the bullish stance on the stock. The combination of the raised price target and the maintained positive rating suggests that analysts see strong potential in Haemonetics' future growth and market position.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1127107226"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1127107226\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1127107226?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-07 22:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1127107226","market":"hk","top_or_hot":-1,"title":"Stock Track | Haemonetics Soars 5.27% as Needham Raises Price Target to $78","media":"Stock Track","content":"<p>Haemonetics (HAE) stock is soaring 5.27% in pre-market trading on Friday, following a positive analyst action. The surge comes after Needham raised its price target for the company from $68 to $78, signaling increased confidence in Haemonetics' future performance.</p>\n\n<p>The raised price target represents a significant vote of confidence in Haemonetics' business prospects. This optimistic outlook from Needham appears to be driving investor enthusiasm, resulting in the stock's notable pre-market rally.</p>\n\n<p>Adding to the positive sentiment, Barrington Research has maintained its Outperform rating on Haemonetics, further reinforcing the bullish stance on the stock. The combination of the raised price target and the maintained positive rating suggests that analysts see strong potential in Haemonetics' future growth and market position.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Haemonetics Soars 5.27% as Needham Raises Price Target to $78</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Haemonetics Soars 5.27% as Needham Raises Price Target to $78\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-11-07 22:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Haemonetics (HAE) stock is soaring 5.27% in pre-market trading on Friday, following a positive analyst action. The surge comes after Needham raised its price target for the company from $68 to $78, signaling increased confidence in Haemonetics' future performance.</p>\n\n<p>The raised price target represents a significant vote of confidence in Haemonetics' business prospects. This optimistic outlook from Needham appears to be driving investor enthusiasm, resulting in the stock's notable pre-market rally.</p>\n\n<p>Adding to the positive sentiment, Barrington Research has maintained its Outperform rating on Haemonetics, further reinforcing the bullish stance on the stock. The combination of the raised price target and the maintained positive rating suggests that analysts see strong potential in Haemonetics' future growth and market position.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HAE","symbol_name":"美国血液技术","start_time":0,"source_url":"","article_id":"1127107226","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1127107226","pubTimestamp":1762527528,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Haemonetics (HAE) stock is soaring 5.27% in pre-market trading on Friday, following a positive analyst action. The surge comes after Needham raised its price target for the company from $68 to $78,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HAE":"美国血液技术"},"translate_title":"股票追踪|Needham将目标价上调至78美元，Haemonetics飙升5.27%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HAE":1},"content_text":"Haemonetics (HAE) stock is soaring 5.27% in pre-market trading on Friday, following a positive analyst action. The surge comes after Needham raised its price target for the company from $68 to $78, signaling increased confidence in Haemonetics' future performance.\nThe raised price target represents a significant vote of confidence in Haemonetics' business prospects. This optimistic outlook from Needham appears to be driving investor enthusiasm, resulting in the stock's notable pre-market rally.\nAdding to the positive sentiment, Barrington Research has maintained its Outperform rating on Haemonetics, further reinforcing the bullish stance on the stock. The combination of the raised price target and the maintained positive rating suggests that analysts see strong potential in Haemonetics' future growth and market position.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}